PFE (VIDEO!), CLNO, SPG, BAP, CAT – Market Watch From DrStockPick.com!

    Pfizer Inc. (NYSE: PFE) announced the top-line primary endpoint result for Toviaz (fesoterodine fumarate) Study A0221049 – Efficacy and Safety of Fesoterodine Flexible Dose Regimen in Vulnerable Elderly Patients with Overactive Bladder. The study met its primary endpoint: treatment with Toviaz was found to be statistically significantly superior to placebo in reducing the […]